NCT01920893 - An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Nasal Polyps

Interventions

DRUG

Placebo (for dupilumab)

Solution for injection; Subcutaneous injection.

DRUG

Dupilumab

Solution for injection; Subcutaneous injection.

DRUG

Mometasone furoate nasal spray

Nasal spray, 2 actuations in each nostril twice daily.

Trial Locations (14)

3500

Investigational Site Number 056002, Leuven

9000

Investigational Site Number 056001, Ghent

11407

Investigational Site Number 724005, Jerez de la Frontera

14186

Investigational Site Number 752001, Stockholm

15213

Investigational Site Number 840009, Pittsburgh

28040

Investigational Site Number 724004, Madrid

46014

Investigational Site Number 724003, Faitanar

80230

Investigational Site Number 840015, Denver

90274

Investigational Site Number 840014, Rolling Hills Estates

97035

Investigational Site Number 840002, Lake Oswego

02114

Investigational Site Number 840013, Boston

08036

Investigational Site Number 724001, Barcelona

08907

Investigational Site Number 724002, L'Hospitalet de Llobregat

171 76

Investigational Site Number 752002, Stockholm